Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 393

Results For "HR"

5952 News Found

Lupin to acquire two inhalation brands from Sunovion for US$75 million
News | October 20, 2022

Lupin to acquire two inhalation brands from Sunovion for US$75 million

The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.


Health Minister Mandaviya inaugurates CGHS Wellness Centres
Policy | October 20, 2022

Health Minister Mandaviya inaugurates CGHS Wellness Centres

CGHS would give robust coverage to pensioners and with new innovations and practices


MedScapeIndia launches a poster of 'Girl Child Anthem'
News | October 20, 2022

MedScapeIndia launches a poster of 'Girl Child Anthem'

The girl child anthem will portray a celebration of a girl child.


Mandaviya directs officials to focus on strengthening genome sequencing for early detection of variants
News | October 19, 2022

Mandaviya directs officials to focus on strengthening genome sequencing for early detection of variants

He also highlighted the need for community awareness for continued implementation of the Covid Appropriate Behaviour (CAB) especially in view of the upcoming festival season


Inceptua Early Access and Sentynl Therapeutics launch early access program for Nulibry for pediatric patients
News | October 19, 2022

Inceptua Early Access and Sentynl Therapeutics launch early access program for Nulibry for pediatric patients

MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism resulting in toxic sulfite levels causing neurologic sequelae


WHO, FAO, UNEP and WOAH launch One Health Joint Plan of Action
Policy | October 18, 2022

WHO, FAO, UNEP and WOAH launch One Health Joint Plan of Action

This first joint plan on One Health aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats


Zydus receives tentative approval from USFDA for Roflumilast tablets
Drug Approval | October 18, 2022

Zydus receives tentative approval from USFDA for Roflumilast tablets

Roflumilast Tablets had annual sales of US $248 million in the United States according to IQVIA data


Aster Pharmacy enters KSA in partnership with Al Hokair Holding Group
News | October 18, 2022

Aster Pharmacy enters KSA in partnership with Al Hokair Holding Group

Both the partners will work towards bringing Aster Pharmacy’s in-house quality care products to serve the healthcare needs of the local population in KSA


CHMP recommends conditional marketing authorization for Spesolimab for generalized pustular psoriasis flares
News | October 17, 2022

CHMP recommends conditional marketing authorization for Spesolimab for generalized pustular psoriasis flares

CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in